“India is at an exciting but challenging time”

Reserve Bank of India’s new deputy governor Viral Acharya said India has the massive potential to become an economic powerhouse

GN Bureau | January 20, 2017


#debuty governor   #Viral Acharya   #Reserve Bank of India   #RBI  
Viral Acharya
Viral Acharya

“India is at an exciting but challenging time,” said Viral Acharya who takes over as RBI’s deputy governor on Friday.

“As one of the world’s fastest growing economies, India has the massive potential to become an economic powerhouse,” said Acharya, the C.V. Starr Professor of Economics at the Department of Finance of NYU Stern.
 
In a statement on NYU Stern, Acharya said that he was thrilled to have the “opportunity to help advance India’s economy by contributing to policies at the RBI that can ensure the country’s stable growth and are at the same time globally responsible”.
 
Peter Henry, dean of NYU Stern, said: “We are extremely proud of our colleague Viral Acharya who has been named deputy governor of the RBI,” said “An outstanding and prolific scholar, Viral will undoubtedly bring breadth, depth and real-world insight to this prestigious policy post in such an important emerging market in the global economy.”
 
In his new role, professor Acharya will be in charge of monetary policy, foreign exchange and market operations, as well as research and statistics.
 
Acharya’s primary research interests are in the regulation of banks and financial institutions, measurement of systemic risk, and understanding the nexus between sovereign and financial sector credit risks.
 

Comments

 

Other News

BFSI Needs Military-grade Cybersecurity Solutions to Detect the Most Advanced Attacks: Deloitte

In such unprecedented times, businesses are facing different kinds of risk, which has

“New guidelines suppress digital, social media, and OTT platforms”

The government’s recent notification to regulate digital media is an attempt to suppress all social media platforms including digital news platforms, Dr. Shama Mohamed, Congress Spokesperson, has said. Only digital news platforms are able to say what they want to say, so the government

Covaxin Phase 3 clinical trial shows 81% efficacy

India’s first indigenously produced Covid-19 vaccine, Covaxin, has shown an interim efficacy of 81% in Phase III trials for preventing the virus. Covaxin has been developed in India jointly by the Indian Council of Medical Research (ICMR) along with Bharat Biotech International Limited (BBIL). &

In Mumbai, 29 private hospitals join vaccination drive

In order to expand the vaccination drive, the centre has allowed 29 private hospitals in Mumbai not empanelled in central and state health schemes to be designated as Covid Vaccination Centres (CVC). After a virtual meeting with the chief minister and the BMC commissioner Tuesday evening, th

Spectrum auction concludes; response better than expected

India on Tuesday concluded the spectrum auction after a total of six rounds of bidding. The authorities described the response as better than expected, with total bids valued at Rs 77,814.80 crore. The quality of service and customer experience is expected to improve with deployment of additional spectrum

Covid-19 has increased nutrition gap. Public feeding programmes need to be enhanced

One of the most significant setbacks from the massive upheaval caused by the Covid-19 pandemic is its effect on food and nutrition security. The pandemic has compounded the already rampant social inequity by adversely affecting the socio-economic status of millions of families across the nation. In the giv

Visionary Talk Series with Dr. Shama Mohamed On the present state of Governance



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter